. 2010 Nov 5;31(11):1515–1522. doi: 10.1038/aps.2010.114

Table 4. Steady-state pharmacokinetics parameters after receiving panaxatrol disuccinate sodium 100 mg·m⁻² for the 30-day continuous intravenous injection.

Parameters	AUC_ss (mg·L⁻¹·h)	C_max (mg·L⁻¹)	C_min (mg·L⁻¹)	C_av (mg·L⁻¹)	DF
No 1	0.432	1.909	0.575	0.018	74.06
No 2	0.527	2.169	0	0.022	98.76
No 3	2.445	35.97	0	0.102	353.12
No 4	0.253	2.539	0.704	0.011	173.91
No 5	0.497	0.318	0.128	0.021	9.18
No 6	20.582	29.623	0	0.858	34.54
No 7	1.008	7.649	0	0.042	182.06
No 8	2.926	31.496	0	0.122	258.33
Mean	3.584	13.959	0.176	0.15	148.00
SD	6.941	15.482	0.292	0.289	117.18

Table 4. Steady-state pharmacokinetics parameters after receiving panaxatrol disuccinate sodium 100 mg·m−2 for the 30-day continuous intravenous injection.